Immunoreaction with anti-SGLT2 in STZ-administered mice was significantly stronger with malocclusion than without malocclusion, suggesting that malocclusion increases the expression of SGLT-2 under hyperglycemia conditions. This evidence concerns the gene SLC5A2 and Hyperglycemia.